[Teva] they may only accuse NVS with stealing some Copaxone trade secrets - not all of them.
This would obviously help vis-à-vis the Copaxone CP, but it might hurt the chances for Teva to prevail in the lawsuit and it would likely reduce the monetary damages if they did prevail.